Angiotensin-Converting Enzyme 2 Activity Is Associated With Embolic Stroke of Undetermined Source

Stroke. 2021 Jul;52(7):e324-e325. doi: 10.1161/STROKEAHA.121.034135. Epub 2021 Jun 11.

Authors

Affiliations

¹ Eastern Health, Monash University, Melbourne, Victoria, Australia (J.K.S., H.D., B.C., L.R., J.C.C., M.G., J.N., A.W.T.).
² Royal Melbourne Hospital, Victoria, Australia (J.M.K.).
³ Department of Medicine, University of Melbourne, Victoria, Australia (A.N.K., S.K.P., L.M.B., A.W.T.).

PMID: 34111949
DOI: 10.1161/STROKEAHA.121.034135

Abstract

[Figure: see text].

Keywords: angiotensins; atrial fibrillation; biomarkers; embolic stroke; fibrosis.

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Aged, 80 and over
Angiotensin-Converting Enzyme 2 / blood*
Biomarkers / blood
Cross-Sectional Studies
Embolic Stroke / blood*
Embolic Stroke / diagnostic imaging*
Enzyme Activation / physiology
Female
Humans
Male
Middle Aged

Substances

Biomarkers
ACE2 protein, human
Angiotensin-Converting Enzyme 2